MAPT and tauopathy: We achieve these goals by analysing histological tau data from 4 individual studies comprising 11 experimental conditions, all of which use P301S-tau-expressing mice Boluda et al. (2015); Hurtado et al. (2010); Iba et al. (2013); Kaufman et al. (2016), to perform a meta-analysis of mouse tauopathy at a whole-brain level in the context of network spread of tau.